You are viewing the site in preview mode

Skip to main content

Table 1 Study enrollment and follow-up schedule, detailing specific interventions and assessments

From: Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial

Time window Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6 Visit 7 Visit 8
Screen
− 28 to 0 days 		Baseline
0 day 		4 weeks±14 days 8 weeks±14 days 12 weeks±14 days 24 weeks±14 days 36 weeks±14 days 48 weeks±14 days
Sign informed consent X        
Inclusion and exclusion criteria X        
Demography X        
Signs and symptoms X   X X X X X X
HIV screening X        
HIV confirmation X        
Hematological analysis X   X X X X X X
Urinalysis X        
Clinical chemistry studies X   X X X X X X
Blood CMV antibodies IgG/IgM X      X   X
Blood/aqueous or vitreous CMV DNA X   X   X X X X
Urine pregnancy test X        
Lymphocyte subset X   X X X X   X
Quantitative plasma HIV-1 RNA X      X   X
Electrocardiogram X        
Ophthalmological examination X   X   X X X X
IRU    X X X X X X
Therapeutic regimens (anti-CMV and ART) X X X X X X X X
Concomitant medications   X X X X X X X
Adverse events   X X X X X X X
Back to article page

Trials

ISSN: 1745-6215